Cargando…
Cytotoxicity of Amrubicin, a Novel 9‐Aminoanthracycline, and Its Active Metabolite Amrubicinol on Human Tumor Cells
Amrubicin, a completely synthetic 9‐aminoanthracycline derivative, was previously shown to have potent antitumor activities against various human tumor xenografts. In this study, the in vitro activities of amrubicin and its major metabolite, amrubicinol, were examined using 17 human tumor cell lines...
Autores principales: | Yamaoka, Takashi, Hanada, Mituharu, Ichii, Shinji, Morisada, Shinya, Noguchi, Toshihiro, Yanagi, Yoshikazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921698/ https://www.ncbi.nlm.nih.gov/pubmed/9849587 http://dx.doi.org/10.1111/j.1349-7006.1998.tb00498.x |
Ejemplares similares
-
Tumor‐selective Distribution of an Active Metabolite of the 9‐Aminoanthracycline Amrubicin
por: Noguchi, Toshihiro, et al.
Publicado: (1998) -
Uptake and Intracellular Distribution of Amrubicin, a Novel 9‐Amino‐anthracycline, and Its Active Metabolite Amrubicinol in P388 Murine Leukemia Cells
por: Yamaoka, Takashi, et al.
Publicado: (1999) -
In vivo Efficacy and Tumor‐selective Metabolism of Amrubicin to Its Active Metabolite
por: Noguchi, Toshihiro, et al.
Publicado: (1998) -
Toxicological Aspects of a Novel 9‐Aminoanthracycline, SM‐5887
por: Morisada, Shinya, et al.
Publicado: (1989) -
Antitumor Activities of a Novel 9‐Aminoanthracycline (SM‐5887) against Mouse Experimental Tumors and Human Tumor Xenografts
por: Morisada, Shinya, et al.
Publicado: (1989)